216 related articles for article (PubMed ID: 20087372)
1. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.
Izuhara Y; Yamaoka N; Kodama H; Dan T; Takizawa S; Hirayama N; Meguro K; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2010 May; 30(5):904-12. PubMed ID: 20087372
[TBL] [Abstract][Full Text] [Related]
2. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
[TBL] [Abstract][Full Text] [Related]
4. Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
Noguchi R; Kaji K; Namisaki T; Moriya K; Kawaratani H; Kitade M; Takaya H; Aihara Y; Douhara A; Asada K; Nishimura N; Miyata T; Yoshiji H
Mol Med Rep; 2020 Oct; 22(4):2948-2956. PubMed ID: 32945412
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PAI-1: a new anti-thrombotic approach.
Wu Q; Zhao Z
Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):27-42. PubMed ID: 12769655
[TBL] [Abstract][Full Text] [Related]
6. T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in rats.
Ohtani A; Murakami J; Hirano-Wakimoto A
Eur J Pharmacol; 1997 Jul; 330(2-3):151-6. PubMed ID: 9253948
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pyrrolin-2-one derivatives synthesized by a new practical method as inhibitors of plasminogen activator inhibitor-1 (PAI-1).
Miyazaki H; Miyake T; Terakawa Y; Ohmizu H; Ogiku T; Ohtani A
Bioorg Med Chem Lett; 2010 Jan; 20(2):546-8. PubMed ID: 19969458
[TBL] [Abstract][Full Text] [Related]
8. Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model.
Jeong BY; Uddin MJ; Park JH; Lee JH; Lee HB; Miyata T; Ha H
PLoS One; 2016; 11(6):e0157012. PubMed ID: 27258009
[TBL] [Abstract][Full Text] [Related]
9. A long-acting PAI-1 inhibitor reduces thrombus formation.
Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis.
Berry CN; Lunven C; Lechaire I; Girardot C; O'Connor SE
Br J Pharmacol; 1998 Sep; 125(1):29-34. PubMed ID: 9776340
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of pyrrolin-2-one compounds, a series of plasminogen activator inhibitor-1 inhibitors.
Miyazaki H; Ogiku T; Sai H; Moritani Y; Ohtani A; Ohmizu H
Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):979-85. PubMed ID: 19721260
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat.
Létienne R; Leparq-Panissié A; Calmettes Y; Nadal-Wollbold F; Perez M; Le Grand B
Biochem Pharmacol; 2010 Jun; 79(11):1616-21. PubMed ID: 20188709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 1,4-diphenylbutadiene derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
Miyazaki H; Sai H; Ohmizu H; Murakami J; Ohtani A; Ogiku T
Bioorg Med Chem; 2010 Mar; 18(5):1968-79. PubMed ID: 20138768
[TBL] [Abstract][Full Text] [Related]
14. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
[TBL] [Abstract][Full Text] [Related]
15. [Plasminogen activator inhibitor-1 (PAI-1) molecule: new physiological roles and clinical applications].
Dan T; Ichimura A; Pelisch N; Miyata K; Akahori K; Miyata T
Rinsho Ketsueki; 2014 Apr; 55(4):396-404. PubMed ID: 24850450
[No Abstract] [Full Text] [Related]
16. A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration.
Ichimura A; Matsumoto S; Suzuki S; Dan T; Yamaki S; Sato Y; Kiyomoto H; Ishii N; Okada K; Matsuo O; Hou FF; Vaughan DE; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):935-42. PubMed ID: 23471233
[TBL] [Abstract][Full Text] [Related]
17. Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?
Bird E; Tamura J; Bostwick JS; Steinbacher TE; Stewart A; Liu Y; Baumann J; Feyen J; Tamasi J; Schumacher WA
Thromb Res; 2007; 120(4):549-58. PubMed ID: 17229457
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.
Honjo K; Munakata S; Tashiro Y; Salama Y; Shimazu H; Eiamboonsert S; Dhahri D; Ichimura A; Dan T; Miyata T; Takeda K; Sakamoto K; Hattori K; Heissig B
FASEB J; 2017 Jun; 31(6):2625-2637. PubMed ID: 28270519
[TBL] [Abstract][Full Text] [Related]
19. Study on the antithrombotic effect and physiological mechanism of okanin.
Liu Y; Xiong B; Qiu X; Hao H; Sha A
Biomed Pharmacother; 2022 Sep; 153():113358. PubMed ID: 35785699
[TBL] [Abstract][Full Text] [Related]
20. Dual-reporter high-throughput screen for small-molecule
Reinke AA; Li SH; Warnock M; Shaydakov ME; Guntaka NS; Su EJ; Diaz JA; Emal CD; Lawrence DA
J Biol Chem; 2019 Feb; 294(5):1464-1477. PubMed ID: 30510136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
